| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 309,612 | 396,589 | 532,513 | 590,694 | | Cost of Revenue | 209,223 | 232,777 | 258,203 | 268,868 | | | Gross Profit | 100,389 | 163,812 | 274,310 | 321,826 | | | Operating Expenses | | Research Development | 82,609 | 95,266 | 114,361 | 116,470 | | Selling General and Administrative | 90,061 | 127,433 | 125,011 | 101,945 | | Non Recurring |
-
| 446,744 |
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (72,281) | (505,631) | 34,938 | 103,411 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 8,723 | 1,381 | 18,050 | 4,873 | | Earnings Before Interest And Taxes | (63,558) | (504,250) | 52,988 | 108,284 | | Interest Expense | 13,609 | 13,853 | 13,873 | 10,767 | | Income Before Tax | (77,167) | (518,103) | 39,115 | 97,517 | | Income Tax Expense | 5,660 | (83,849) | 19,826 | 21,507 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (82,827) | (434,254) | 19,289 | 76,010 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (82,827) | (434,254) | 19,289 | 76,010 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($82,827) | ($434,254) | $19,289 | $76,010 |
|
0.45% Nasdaq 
0.20%
Income Statement
